These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 8658832)
21. High serum cholestanol and low campesterol/sitosterol ratio indicate severe liver damage and liver transplantation in primary biliary cirrhosis. Nikkilä K; Höckerstedt K; Miettinen TA Transplant Proc; 1992 Feb; 24(1):383-6. PubMed ID: 1539326 [No Abstract] [Full Text] [Related]
22. Glutathione-S-transferase as a marker of acute graft rejection in orthotopic liver transplantation. Diaz J; Carrascosa C; Acosta F; Marin C; Bueno FS; Cañizares F; Serrano E; Ramirez P; Parrilla P; Martinez P Transplant Proc; 1995 Aug; 27(4):2305. PubMed ID: 7652818 [No Abstract] [Full Text] [Related]
23. Early detection of graft dysfunction after orthotopic liver transplantation in man by serum and biliary bile acid analysis. Baumgartner U; Schölmerich J; Kremer B; Streckfuss G; Henne-Bruns D; Mergard BL; Kraemer-Hansen H; Farthmann EH Hepatogastroenterology; 1995; 42(6):950-60. PubMed ID: 8847051 [TBL] [Abstract][Full Text] [Related]
24. Leucocyte elastase in the early diagnosis of rejection after liver transplantation. Pfeiffer T; Rudy T; Erhard J; Eigler FW Transplant Proc; 1993 Aug; 25(4):2662-3. PubMed ID: 8356713 [No Abstract] [Full Text] [Related]
25. Liver biopsy interpretation for causes of late liver allograft dysfunction. ; Demetris AJ; Adeyi O; Bellamy CO; Clouston A; Charlotte F; Czaja A; Daskal I; El-Monayeri MS; Fontes P; Fung J; Gridelli B; Guido M; Haga H; Hart J; Honsova E; Hubscher S; Itoh T; Jhala N; Jungmann P; Khettry U; Lassman C; Ligato S; Lunz JG; Marcos A; Minervini MI; Mölne J; Nalesnik M; Nasser I; Neil D; Ochoa E; Pappo O; Randhawa P; Reinholt FP; Ruiz P; Sebagh M; Spada M; Sonzogni A; Tsamandas AC; Wernerson A; Wu T; Yilmaz F Hepatology; 2006 Aug; 44(2):489-501. PubMed ID: 16871565 [TBL] [Abstract][Full Text] [Related]
26. Serum HLA class I soluble antigens: a marker of acute rejection following liver transplantation. Renna Molajoni E; Puppo F; Brenci S; Scudeletti M; Cinti P; Alfani D; Indiveri F; Cortesini R Transplant Proc; 1995 Feb; 27(1):1155-6. PubMed ID: 7878828 [No Abstract] [Full Text] [Related]
27. Arterial blood ketone body ratio as an indicator for viability of donor livers. Ozaki N; Gubernatis G; Ringe B; Oellerich M; Washida M; Yamaoka Y; Ozawa K; Pichlmayr R Transplant Proc; 1991 Oct; 23(5):2487-9. PubMed ID: 1926445 [No Abstract] [Full Text] [Related]
28. Treatment of acute rejection following liver transplantation: a comparison between methylprednisolone and hydrocortisone. Barron PT; Jamieson NV; Calne RY Transplant Proc; 1991 Aug; 23(4):2266. PubMed ID: 1871868 [No Abstract] [Full Text] [Related]
29. Association between donor-recipient serum sodium differences and orthotopic liver transplant graft function. Cywinski JB; Mascha E; Miller C; Eghtesad B; Nakagawa S; Vincent JP; Pesa N; Na J; Fung JJ; Parker BM Liver Transpl; 2008 Jan; 14(1):59-65. PubMed ID: 18161840 [TBL] [Abstract][Full Text] [Related]
30. The use of fine-needle aspiration biopsy in detection of acute rejection in children after liver transplantation. Their M; Lautenschlager I; von Willebrand E; Höckerstedt K; Holmberg C; Jalanko H Transpl Int; 2002 May; 15(5):240-7. PubMed ID: 12012045 [TBL] [Abstract][Full Text] [Related]
31. Interleukin-15 production during liver allograft rejection in humans. Conti F; Frappier J; Dharancy S; Chereau C; Houssin D; Weill B; Calmus Y Transplantation; 2003 Jul; 76(1):210-6. PubMed ID: 12865812 [TBL] [Abstract][Full Text] [Related]
32. Routine monitoring of liver grafts by transplant aspiration cytology: clinical experience with 3000 TACs. Schlitt HJ; Nashan B; Ringe B; Wonigeit K; Pichlmayr R Transplant Proc; 1993 Apr; 25(2):1970-1. PubMed ID: 8470246 [No Abstract] [Full Text] [Related]
33. Soluble interleukin 2 receptor level in liver allograft recipients: an indicator of rejection. Perkins JD; Nelson DL; Rakela J; Grambsch PM; Krom RA Transplant Proc; 1989 Feb; 21(1 Pt 2):2275-6. PubMed ID: 2540568 [No Abstract] [Full Text] [Related]
34. Clinical validation of an artificial neural network trained to identify acute allograft rejection in liver transplant recipients. Hughes VF; Melvin DG; Niranjan M; Alexander GA; Trull AK Liver Transpl; 2001 Jun; 7(6):496-503. PubMed ID: 11443576 [TBL] [Abstract][Full Text] [Related]
35. Hyaluronic acid in the assessment of liver graft function. Pollard SG; Forbes MA; Metcalfe SM; Cooper EH; Calne RY Transplant Proc; 1990 Oct; 22(5):2301-2. PubMed ID: 2219379 [No Abstract] [Full Text] [Related]
36. Histopathology of liver following transplantation: an experience in Taiwan. Eng HL; Lee N; Chen CL; Chen YS; Chen WJ Transplant Proc; 1996 Jun; 28(3):1689-90. PubMed ID: 8658841 [No Abstract] [Full Text] [Related]
37. c-Kit-positive mast cells in portal tracts cannot be used to distinguish acute cellular rejection from recurrent hepatitis C infection in liver allografts. Doria C; di Francesco F; Marino IR; Ramirez CB; Frank A; Iaria M; Galati SA; Farber JL Transplant Proc; 2006 Dec; 38(10):3597-600. PubMed ID: 17175342 [TBL] [Abstract][Full Text] [Related]
38. Semiquantitative histologic evaluation of the liver in patients after liver transplantation. Poo JL; Hernández-Pando R; Diliz H; Morales L; Marin E; Panduro A; Kershenobich D; Uribe M Transplant Proc; 1992 Oct; 24(5):1973-5. PubMed ID: 1412935 [No Abstract] [Full Text] [Related]
39. High serum soluble CD30 does not predict acute rejection in liver transplant patients. Matinlauri I; Höckerstedt K; Isoniemi H Transplant Proc; 2006 Dec; 38(10):3601-4. PubMed ID: 17175343 [TBL] [Abstract][Full Text] [Related]